Cognitive peptides are particularly well-suited for older adults, with extensive research in age-related cognitive decline and neurodegenerative conditions. Cerebrolysin and Pinealon show strong safety profiles in elderly populations, while Semax and Selank are well-tolerated across all age groups.
Geriatric studies demonstrate significant cognitive benefits in adults over 60 with minimal adverse effects.